海正生材: 浙江海正生物材料股份有限公司股东减持股份结果公告

Group 1 - The major shareholder, Hunan Zhongqi Dongjian Private Equity Investment Partnership, held 10,457,516 shares, accounting for 5.16% of the total share capital before the reduction plan [1] - The reduction plan was disclosed on March 7, 2025, with the intention to reduce shares due to funding needs, allowing for a maximum reduction of 1% within three months [1] - As of June 16, 2025, the shareholder had completed the reduction of 2,026,780 shares through centralized bidding, resulting in a current holding of 8,430,736 shares, or 4.16% [2][3] Group 2 - The reduction price range was between 9.85 and 15.54 yuan per share, with a total reduction amount of 22,068,414.24 yuan [2] - The actual reduction was consistent with the previously disclosed plan, confirming that the minimum reduction quantity was achieved [3]